RESUMO
The development of metastasis is the most significant cause of death for both canine and human patients with osteosarcoma (OS). Ezrin has been associated with tumour progression and metastasis in human, canine and murine OS. Ezrin activation is dynamically regulated by protein kinase C (PKC) during metastatic progression in human and murine OS. To include the dog in the development of therapeutics that target ezrin biology, we characterized four new canine OS cell lines and confirmed the relationship between PKC and ezrin in these cells. Three of four cell lines formed tumours in mice that were histologically consistent with OS. All cell lines were markedly aneuploid and expressed ezrin and PKC. Finally, both ezrin phosphorylation and cell migration were inhibited using a PKC inhibitor. These data suggest that an association between PKC-mediated activation of ezrin and the metastatic phenotype in canine OS cells.
Assuntos
Neoplasias Ósseas/veterinária , Proteínas do Citoesqueleto/metabolismo , Doenças do Cão/metabolismo , Osteossarcoma/veterinária , Proteína Quinase C/metabolismo , Doenças dos Roedores/metabolismo , Animais , Neoplasias Ósseas/metabolismo , Linhagem Celular Tumoral , Movimento Celular , Cães , Feminino , Proteínas de Membrana/metabolismo , Camundongos , Camundongos SCID , Proteínas dos Microfilamentos/metabolismo , Metástase Neoplásica , Osteossarcoma/metabolismo , Fosforilação , Transdução de Sinais , CicatrizaçãoRESUMO
Nonrandom aberrations of chromosome 7 have been described in various hematopoietic disorders. We describe here two unrelated families with the same constitutional inversion of chromosome 7 [inv(7)(q11.2q22)]. The probands in both families had acute leukemia and cytogenetic analysis revealed that the inversion was the sole cytogenetic abnormality in the bone marrow at diagnosis. There is a history of hematologic diseases in one of these families that included a son who is a carrier of this constitutional inversion. The distal inversion breakpoint lies within the common region of chromosome loss identified in some myeloid diseases. These observations raise the possibility that this inherited chromosome rearrangement could result in a mutation of a tumor suppressor gene and possibly represent a predisposing event for the development of leukemia in these individuals.